Substance P
Also known as: SP, Tachykinin
A neuropeptide involved in pain transmission and neuroinflammation. Researched for neuroprotection and cognitive function through NK1 receptor modulation.
Beginner Basics
Plain-English guide to Substance P
What it does
Substance P is a signaling molecule in your brain that researchers study for managing pain signals and reducing brain inflammation. Scientists use it to explore how it might support brain health and thinking ability.
Typical dose
Researchers typically use 0.1 to 1 microgram injected under the skin once or twice daily, starting at the lowest dose and adjusting based on how your body responds.
When to inject
Morning and/or evening injections help maintain consistent activity in the brain; consistency matters more than exact timing.
Storage
Keep the dry powder in a cool, dark place at room temperature until mixed. Once mixed with liquid, store in the refrigerator and use within the timeframe specified by your supplier.
First-timer tip
Start with the lowest dose (0.1 mcg) and go slowly-this peptide is very potent, so small changes can make a noticeable difference in how you feel.
On This Page
Research Status
Clinical trials
For research purposes only. Not approved for human use. Not medical advice.
Research Areas
Side Effects
Mild erythema, swelling, or itching at the injection site typically resolves within 1-2 hours. Rotate injection sites to minimize local reactions. Apply ice if needed.
May occur within 1-4 hours of injection. Usually self-resolving. Ensure adequate hydration and consider timing of injection relative to meals.
Transient vasodilation may occur shortly after injection. Typically resolves within 30 minutes. Not dangerous but may be uncomfortable.
May occur if injected on an empty stomach. Take with a light meal or snack. Usually mild and self-limiting.
May occur if standing too quickly after injection. Sit or lie down for 5-10 minutes post-injection if this occurs.
Substance P is involved in stress and anxiety pathways. Some users report transient mood changes. Monitor closely and discontinue if significant anxiety develops. Consult a healthcare provider.
Chronic repeated injections at the same site can cause localized fat loss or hypertrophy. Strict site rotation (minimum 1 inch between injections) is essential to prevent this. If lipodystrophy develops, discontinue injections at that site for at least 4-6 weeks.
Anaphylaxis or severe allergic reactions are rare but possible. Symptoms include difficulty breathing, throat tightness, severe swelling, or rash. Seek emergency medical attention immediately if these occur. Have an epinephrine auto-injector available if you have a history of peptide allergies.
Substance P can affect cardiovascular tone. If you experience rapid heartbeat, chest discomfort, or palpitations, discontinue use and seek medical evaluation.
Dosing Reference
| Parameter | Value |
|---|---|
| Dose range | 0.1-1 mcg |
Frequency, timing and route - members only | |
Research disclaimer
Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution Guide
Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution
Do not shake the vial vigorously; gentle swirling prevents peptide degradation
Discard immediately if the solution appears cloudy, discolored, or contains visible particles
Use within 30 days of reconstitution when stored at 2-8°C
Do not freeze the reconstituted solution; freezing may denature the peptide
Use the PeptideVolt reconstitution calculator for your exact concentration
Molecular and Pharmacological Data
| Molecular weight | 1347.6 |
| Half-life | Approximately 2-3 minutes in plasma; longer in CNS tissue |
| Sequence | Members only |
Substance P is an 11-amino acid neuropeptide that acts primarily as a neurotransmitter and neuromodulator by binding to neurokinin-1 (NK1) receptors on neurons and immune cells. It plays a central role in pain signal transmission, neuroinflammation, and stress responses. Research suggests that modulating substance P signaling may reduce neuroinflammatory cascades, support neuroprotection, and enhance cognitive function through altered pain perception and immune regulation.
Track your Substance P research
Free account. No credit card required.
Recent Research
Prisoners of the Body: The Link Between Interoception and Sleep Paralysis.
Single-Cell Transcriptomic Mapping of PD-L1/TLR4 Remodeling Informs Topical Immunoprevention Timing in Skin Carcinogenesis.
Four new species of Microdochium (Microdochiaceae, Xylariales) based on morphology and multilocus phylogeny from Hainan, China.
Source: PubMed / NCBI. Updated daily. Articles are listed for research reference only.
Research Citations
5 sources
Quartara L, Maggi CA. (1997). The tachykinin NK1 receptor. Part I: ligands and mechanism of action. Neuropeptides. 31(6):537-563. PMID: 9574819
Cascieri MA, Macleod AM. (2007). Emerging roles for substance P and the neurokinin-1 receptor in depression and anxiety disorders. Bioorganic & Medicinal Chemistry Letters. 17(22):6144-6149. DOI: 10.1016/j.bmcl.2007.09.047
Ebner K, Singewald N. (2006). The role of substance P in stress and anxiety responses. Amino Acids. 31(3):251-272. PMID: 16868650
Muñoz M, Rosso M, Covenas R. (2010). A new perspective on the role of substance P in cancer biology and immunology: focus on NK-1 receptor selective antagonists. Neuropeptides. 44(5):369-377. PMID: 20580401
Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, Maggi CA. (2004). Tachykinins and tachykinin receptors: a growing family. Life Sciences. 74(12):1445-1463. PMID: 14729395
Related: Cognitive Enhancement
Browse the Research Library
133 peptide profiles and 54 blend profiles with mechanism summaries, dosing data, and reconstitution guides.
View all peptidesStay updated on Substance P research
Weekly digest of new peptide research, stack guides, and platform updates.
Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Substance P is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.